Antibacterial Agents in Clinical Development: An analysis of the antibacterial clinical development pipeline, including tuberculosis

The report shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance. Most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions.
Source: HSR Information Central - Category: International Medicine & Public Health Source Type: news